Results 151 to 160 of about 34,440,044 (184)

Glucagon-Like Peptide-1 Receptor Agonists in Gynecologic Surgery

Obstetrics & Gynecology
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have rapidly expanded beyond their initial role in diabetes management to become prominent agents for weight loss and metabolic optimization. A growing number of patients receiving these therapies are presenting for gynecologic surgery. This narrative review summarizes current evidence on GLP-1 RAs,
Richard, Hsu, Esther, Han, Sarah, Swartz, Michelle, Pacis   +3 more
openaire   +2 more sources

Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy

Journal of Diabetes Investigation, 2023
Tetsuya Kubota, Yukiko Onishi, Tazu Tahara   +2 more
exaly  

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease

International Journal of COPD, 2023
Jun Chen, Jishun Chen, Hang Qian
exaly  

Glucagon-Like Peptide-1 Receptor Agonists and Cancer

JAMA Oncology
Mahyar, Etminan, Connor, Frey, Mohammad A, Mansournia   +2 more
openaire   +4 more sources

Glucagon-Like Peptide-1 Receptor Agonists—How Safe Are They?

JAMA Internal Medicine, 2022
Shanzay, Haider, Kasia J, Lipska
openaire   +2 more sources

Impact of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) on Food Content During Esophagogastroduodenoscopy (EGD)

Annals of Pharmacotherapy, 2022
Jennifer E Stark, Jennifer L Cole
exaly  

GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS

2020
COATES DAVID ANDREW, FIELDS TODD, HO JOSEPH DANIEL, QU FUCHENG   +3 more
openaire   +3 more sources

Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12‐Month Treatment

Journal of the American Heart Association, 2020
Aikaterini Kountouri, Ignatios Ikonomidis, George Dimitriadis   +2 more
exaly  

Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis

Diabetes and Vascular Disease Research, 2016
Tracey Gaspari, Anthony E Dear, Robert E Widdop   +2 more
exaly  

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials

Circulation, 2019
Nikolaus Marx, Eri T Kato, Marc S Sabatine   +2 more
exaly